Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis

Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload

(2017) Karl Toischer et al.   JOURNAL OF CLINICAL INVESTIGATION

Impact of Oxidative Stress on the Heart and Vasculature

(2017) Thomas Münzel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms

(2016) Xiao-Xiao Wang et al.   BASIC RESEARCH IN CARDIOLOGY

DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts

(2016) Chenyang Zhao et al.   FREE RADICAL BIOLOGY AND MEDICINE

Alginate Oligosaccharide Prevents Acute Doxorubicin Cardiotoxicity by Suppressing Oxidative Stress and Endoplasmic Reticulum-Mediated Apoptosis

(2016) Jun-Jie Guo et al.   Marine Drugs

Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma

(2016) Xiang Sun et al.   ONCOLOGY REPORTS

Heart Failure, Left Ventricular Remodeling, and Circulating Nitric Oxide Metabolites

(2016) Julio A. Chirinos et al.   Journal of the American Heart Association

Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis

(2015) L. Dowsett et al.   CIRCULATION

Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure

(2015) Sherin I. Hashem et al.   STEM CELLS

miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia

(2014) Lucio Iannone et al.   BIOCHEMICAL JOURNAL

Cardiovascular remodelling in coronary artery disease and heart failure

(2014) Gerd Heusch et al.   LANCET

Tempol prevents cardiac oxidative damage and left ventricular dysfunction in the PPAR-α KO mouse

(2013) Aziz Guellich et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Effect of CCL5 on dimethylarginine dimethylaminohydrolase-1 production in vascular smooth muscle cells from spontaneously hypertensive rats

(2013) Hye Young Kim et al.   CYTOKINE

Executive Summary: Heart Disease and Stroke Statistics—2012 Update

(2012) et al.   CIRCULATION

Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner

(2012) Shan Wang et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine

(2011) Xinli Hu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Manganese superoxide dismutase: beyond life and death

(2010) Aaron K. Holley et al.   AMINO ACIDS

Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus

(2010) Maike Anderssohn et al.   Diabetes & Vascular Disease Research

Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1–Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine

(2009) Xinli Hu et al.   CIRCULATION

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

(2009) Rainer H. Böger et al.   CIRCULATION